MedPath

Oxaprozin

OXAPROZIN

Approved
Approval ID

e77d2b9e-84df-4733-b654-16e93618efce

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 4, 2011

Manufacturers
FDA

Rebel Distributors Corp

DUNS: 118802834

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Oxaprozin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code21695-100
Application NumberANDA075849
Product Classification
M
Marketing Category
C73584
G
Generic Name
Oxaprozin
Product Specifications
Route of AdministrationORAL
Effective DateSeptember 8, 2010
FDA Product Classification

INGREDIENTS (11)

HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
METHYLCELLULOSE (15 CPS)Inactive
Code: NPU9M2E6L8
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
POLYETHYLENE GLYCOLInactive
Code: 3WJQ0SDW1A
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8H
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
OXAPROZINActive
Quantity: 600 mg in 1 1
Code: MHJ80W9LRB
Classification: ACTIM
POLACRILIN POTASSIUMInactive
Code: 0BZ5A00FQU
Classification: IACT
CARNAUBA WAXInactive
Code: R12CBM0EIZ
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Oxaprozin - FDA Drug Approval Details